Brief: Hyloris Pharmaceuticals FY Net Income EUR -15.762 Million
14/03/2024 06:00
Mar 14 (Reuters) - Hyloris Pharmaceuticals FY operating cash flow EUR -12.726 million. * FY revenue EUR 2.814 million vs. IBES estimate EUR 5.65 million * FY operating result EUR -16.236 million
Recent news on Hyloris Pharmaceuticals SA
See all newsEurope Research Roundup: Akzo Nobel, MTU Aero Engines, Symrise
Brief: Hyloris Pharmaceuticals Says It Obtains Exclusive License Rights In Europe & Turkey From Arbormed For Its Wilson's Disease Therapy
Brief: Hyloris Announces Partnership With Rosemont Pharmaceuticals For Atomoxetine Oral Solution In The U.S.
Brief: Hyloris Announces Positive Study Results For Dofetilide IV
Brief: Hyloris Pharmaceuticals SA Says HY 2024 Revenues (Royalties And Milestones) Increased To EUR 4,2 Million